Pharma & Biotech

The medical technology firm Baxter International finds itself navigating a severe corporate storm, with challenges extending far beyond disappointing quarterly...

Pharmaceutical giant Bristol-Myers Squibb finds itself managing multiple complex situations simultaneously. While the company recently demonstrated robust quarterly results and...

The biotechnology firm Cytokinetics is navigating a period of extreme uncertainty, with two pivotal December events poised to determine its...

Danaher Corporation finds itself navigating turbulent waters as conflicting signals emerge about the company's future trajectory. While the life sciences...

The investment community is holding its breath as Anavex Life Sciences approaches a pivotal moment that will determine its future...

Investor attention is firmly fixed on Bayer as the pharmaceutical giant approaches a pivotal quarterly earnings release next week. Market...

Today represents a watershed moment for biotechnology firm Moderna as it prepares to release quarterly results that will signal whether...

Investors are closely monitoring Assembly Biosciences as the biotech firm approaches a pivotal moment in its corporate timeline. The company's...

Biotechnology firm Ocugen released its third-quarter 2025 financial results this Wednesday, presenting a complex picture of accelerating research investment alongside...

Danish pharmaceutical leader Novo Nordisk delivered a double blow to investors this Wednesday, presenting both another reduction in annual targets...